Blinded by Stress: A Patient and Physician Perspective on Central Serous Chorioretinopathy

Abstract

This commentary is co-authored by a patient with central serous chorioretinopathy (CSC), which is the fourth most common exudative maculopathy. The patient, a young and profiled member of the Danish Parliament, kindly shares his experience living with stress, onset of symptoms, and the experience of being diagnosed with CSC and receiving photodynamic treatment. The experiences of the patient are put into perspective by an ophthalmologist.

Perspectives and Update on the Global Shortage of Verteporfin (Visudyne®)

“…In France, there are still prioritization criteria in effect, and the treating physician can request an ampoule of verteporfin via a form available at the website of Cheplapharm [ 25 ]. Denmark had neither a national prioritization strategy nor a committee to evaluate cases for therapy, and treatment was prioritized at each individual center according to obtained verteporfin from time to time at the discretion of the treating physicians [ 26 , 27 ]. The largest center in Denmark systematically prioritized treatment of CH over cases with CSC.…”